Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (RBR-833prgf) titled 'Study on taste changes and the effect of therapeutic light in Breast Cancer patients undergoing chemotherapy' on Aug. 15.
Study Type: Intervention
Primary Sponsor: Instituto do Cancer do Ceara
Condition:
Tumor Necrosis Factor-alpha
Unilateral Breast Neoplasms
C10.597.751.861.479
Intervention:
This will be a phase II randomized, triple-blind, placebo-controlled clinical trial conducted between 2025 and 2026. It will include two study groups of breast cancer patients initiating antineoplastic chemotherapy: a test group receiving preventive photobiomodulation therapy (PBMT) with low-level red laser, and a placebo gr...